MarketMoodz
Soleno Buyout Lifts 32%; Tech Session Remains Choppy
Neurocrine Biosciences announced an all-cash deal to acquire Soleno Therapeutics for $53 a share, valuing Soleno at about $2.9 billion. The news sparked a choppy midday session as AI-advertising bets, memory hardware names and crypto-linked stocks swung on a slate of catalysts.
Key Takeaways
- Neurocrine Biosciences to acquire Soleno Therapeutics for $53 per share, valuing Soleno at about $2.9 billion.
- AppLovin climbs roughly 5% on bullish analyst notes, with BTIG lifting its Q1 revenue view to $1.82 billion and Wedbush reiterating Outperform.
- Lucid Group reports Q1 deliveries of 3,093 and Gravity SUV pause lasting 29 days due to a supplier quality issue.
- Memory names rebound as Western Digital up over 4%, Seagate up about 6%, and Micron and SanDisk move higher.
- Dow Jones Industrial Average and LyondellBasell slip about 3% after Bank of America downgrades citing Iran-related tailwinds.
People Involved
- No specific individuals mentioned
Entities Involved
- Soleno TherapeuticsTarget company in buyout
- Neurocrine BiosciencesAcquiring company
- AppLovin CorpAdvertising technology company
- BlackRock Inc.ETF sponsor (unverified claim)
- Invesco Ltd.ETF issuer (unverified claim)
- Encompass HealthHealthcare provider
- CMS (Centers for Medicare & Medicaid Services)Policy maker for IRF PPS
- Kratos Defense & Security SolutionsDefense contractor
- Jefferies Group LLCInvestment bank
- Boot Barn HoldingsRetail apparel
- Elbit Systems Ltd.Defense contractor
- Lucid Group, Inc.Electric vehicle manufacturer
- Mara Digital Holdings, Inc.Crypto miner
- Coinbase Global, Inc.Crypto exchange
- Western Digital Corp.Memory technology company
- Seagate Technology Holdings plcHard drive manufacturer
- Morgan StanleyInvestment bank
- Bank of America Corp.Bank and broker
- LyondellBasell IndustriesChemicals
- Dow Inc.Industrial
MarketMoodz Analysis
Investors face a tug-of-war between a sizable acquisition and choppier risk-on trades in AI-advertising, memory hardware and crypto-linked names. The Soleno deal provides a clear M&A catalyst, while other headlines push names like AppLovin, Lucid and Western Digital to swing on multiple fronts.
Historically, such sessions show dispersion: breakout moves in one corner of tech can coexist with headwinds elsewhere, as policy shifts, supply-chain dynamics and earnings updates re-anchor sentiment. M&A spikes tend to lift the target first, then broaden or fade as the market digests terms, synergies and integration risk.
What to watch next: monitor the Soleno close and integration progress, any updates to healthcare policy affecting IRF PPS, Lucid's production recovery and supplier-related fixes, and whether ETF competition or crypto dynamics sustain broader momentum or trigger a mean reversion.
Source: Original Article